GlassScriptPhysician profile
Michael F Esber
NPI 1174597462
$13,034.34
in general payments reported to CMS, 2019-2025
41 companies · $5,518 in 2025
The $5,518 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $1,426 · 2021: $1,748 · 2022: $987 · 2023: $1,665 · 2024: $910 · 2025: $5,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $4,497 · Food and Beverage: $2,518 · Education: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $4,497.18 |
| Food and Beverage | $2,517.69 |
| Education | $1,078.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $5,637.26 | 2022-2025 | Dr Comfort, Cmf |
| Smith+Nephew, INC. | $1,813.57 | 2019-2025 | Grafix Pl, Renasys Touch, Collagenase Santyl |
| Musculoskeletal Transplant Foundation INC. | $1,312.47 | 2019-2025 | |
| Integra Lifesciences Corporation | $499.52 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $299.62 | 2020-2024 | |
| Abbvie INC. | $288.78 | 2021-2024 | |
| Polynovo North America LLC | $281.74 | 2025 | Novosorb Btm |
| Horizon Therapeutics Plc | $272.27 | 2020-2023 | Krystexxa |
| Medtronic, INC. | $272.03 | 2021-2023 | Intellis Adaptivestim |
| Mimedx Group, INC. | $247.49 | 2025 | |
| Stryker Corporation | $205.45 | 2024-2025 | Hoffmann, Minirail |
| Kerecis Limited | $200.80 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Rikco International, LLC | $189.00 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $163.12 | 2021-2025 | Nuzyra |
| Nevro Corp. | $143.77 | 2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $134.30 | 2020-2022 | |
| Abbott Laboratories | $131.86 | 2019-2025 | Ionicrf, Proclaim |
| Medtronic Vascular, INC. | $115.21 | 2019-2020 | |
| Next Science LLC | $82.60 | 2022-2023 | Blastx, Xperience, Surgx |
| Orthofix Medical, INC. | $65.19 | 2019-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $64.57 | 2019 | |
| Solventum Corporation | $59.43 | 2024-2025 | Prevena, V.A.C.Instill, Promogran Prisma |
| Advanced Oxygen Therapy INC. | $59.28 | 2023-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Forthright Medical - Az, LLC | $54.31 | 2024 | |
| Urgo Medical North America, LLC | $41.74 | 2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Bioventus LLC | $40.38 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $37.96 | 2024 | Qutenza |
| Tactile Systems Technology INC | $33.86 | 2021-2023 | Entre Plus, Flexitouch Plus |
| Anika Therapeutics, INC. | $32.19 | 2021 | |
| Merck Sharp & Dohme LLC | $32.02 | 2019 | |
| Alfasigma USA, INC. | $27.09 | 2022 | |
| Convatec INC. | $23.50 | 2024 | |
| Treace Medical Concepts, INC. | $22.66 | 2022 | |
| Acell, INC. | $22.03 | 2020 | |
| Celularity INC. | $22.00 | 2019 | |
| Innovation Technologies INC | $20.77 | 2024 | Irrisept |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.86 | 2021 | |
| Biocomposites INC | $17.35 | 2024 | |
| Amgen INC. | $17.15 | 2025 | Krystexxa |
| Ultragenyx Pharmaceutical INC. | $16.73 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Esber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.